pyrvinium has been researched along with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geldenhuys, WJ; Gibson, LF; Hathaway, QA; Hollander, JM; Martin, KH; Nair, RR; Piktel, D; Rellick, SL; Saralkar, P; Thomas, P | 1 |
1 other study(ies) available for pyrvinium and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Pyrvinium Pamoate Use in a B cell Acute Lymphoblastic Leukemia Model of the Bone Tumor Microenvironment.
Topics: Antineoplastic Agents; Bone and Bones; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Compounding; Drug Liberation; Humans; Nanocapsules; Phosphorylation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrvinium Compounds; Signal Transduction; Tumor Microenvironment | 2020 |